GSZ 2013 - Conference
Postersessions
POSTERSESSION I
Moderation: R. Zweigert, Franz
1) |
A. Limpert, Lübeck |
Approach to sensitize glioma stem cells to standard chemotherapy |
2) |
D. Reichert, Dresden |
Are murine mesenchymal stromal cells a trap for human hematopoietic stem and progenitor cells? |
3) |
EC. Buss, Heidelberg/ Rehovot, Israel |
Mechanisms of mobilization of human primary precursor-B-ALL cells in an in vivo model system by the CXCR4-antagonist AMD3100 and by catecholamines |
4) |
V. Lepperhof, Köln |
Bioluminescence in vivo imaging of genetically selected iPS cell-derived cardiomyocytes after transplantation into infarcted heart |
5) |
S. Ulrich, Hannover |
Differentiation of human pluripotent stem cells into lung epithelial cells |
6) |
F. Schlegel, Leipzig |
A new possibility to reprogram bone marrow stem cells into endothelial like cells |
7) |
M. Schweinlin, Würzburg |
In vitro differentiation of murine embryonic stem cells into intestinal cells |
POSTERSESSION II
Moderation: t.b.a.
8) |
CO. Heras, Köln |
A bioengineered matrix with physiological elasticity facilitates long-term culture of pluripotent stem cell-derived cardiomyocytes |
9) |
Narges-Zare Mehrjardi, Köln/Tehran, Iran |
Genetic manipulation of neural progenitor cells derived from human induced pluripotent stem cells by using zinc finger nucleases |
10) |
R. Zweigert, Hannover |
Generation of endothelial cells from scalable cultures of undifferentiated human pluripotent stem cells |
11) |
A. Witthuhn, Langen |
Line1-mediated retrotransposition in human pluripotent stem cells: consequences for genomic stability of HES and HIPS cells and their derivatives |
12) |
K. Osetek, Hannover |
Young versus aged cell sources - genetic aberrations in iPS cells and the effect of primary cell proliferation on reprogramming efficiency |
13) |
L. Gan and B. Denecke, Aachen |
Transcription factors, microRNAs and their interactions during cardiomyocyte-specific differentiation of murine embrionic stem cells |
14) |
I. Gruh, Hannover |
Optogenetic control of stem cell-derived bioartificial cardiac tissue |
15) |
K. Burkert, Köln |
Monitoring differentiation of pluripotent stem cells to cardiomyocytes by measuring cardiac Troponin T release into the cell culture medium |